Results 331 to 340 of about 172,791 (358)
Some of the next articles are maybe not open access.
The treatment of psoriasis with etanercept
Seminars in Cutaneous Medicine and Surgery, 2005Etanercept is a tumor necrosis factor alpha (TNF-alpha) inhibitor approved for the treatment of psoriasis. Etanercept is a soluble version of the tumor necrosis factor receptor (TNFR) that neutralizes the proinflammatory activity of TNF-alpha, a molecule central to the pathogenesis of psoriasis. Patients receiving etanercept continuously during both 12
openaire +3 more sources
The Journal of Dermatology, 1984 Cancer treatment and survivorship statistics, 2022
Ca-A Cancer Journal for Clinicians, 2022Kimberly D Miller +2 more
exaly
Current treatment and recent progress in gastric cancer
Ca-A Cancer Journal for Clinicians, 2021Smita S Joshi, Brian D Badgwell
exaly
TREATMENT OPTIONS FOR PSORIASIS
AJN, American Journal of Nursing, 1988Elizabeth B. Cockerline +2 more
openaire +3 more sources
1989
The very fact that so many treatments are still in use for psoriasis indicates how far from ideal all of them are. There is also a lack of good trials upon which selection of treatment can be based for the different forms of the disease. Most remedies were introduced on an empirical basis, but, with increasing knowledge, their application has become ...
openaire +2 more sources
The very fact that so many treatments are still in use for psoriasis indicates how far from ideal all of them are. There is also a lack of good trials upon which selection of treatment can be based for the different forms of the disease. Most remedies were introduced on an empirical basis, but, with increasing knowledge, their application has become ...
openaire +2 more sources
Integrative oncology: Addressing the global challenges of cancer prevention and treatment
Ca-A Cancer Journal for Clinicians, 2022Paulo Cáceres Guido +2 more
exaly
Treatment of muscle‐invasive and advanced bladder cancer in 2020
Ca-A Cancer Journal for Clinicians, 2020Vaibhav G Patel +2 more
exaly